Immunomedics (IMMU) Receives US Patent 8,076,140 for Improved Cell Lines for Protein Therapeutic Manufacturing

Go back to Immunomedics (IMMU) Receives US Patent 8,076,140 for Improved Cell Lines for Protein Therapeutic Manufacturing
Immunomedics, Inc. (NASDAQ: IMMU) Delayed: 87.86 --0 (-0%)
Previous Close $87.86    52 Week High $5.44 
Open $238.99    52 Week Low $1.61 
Day High $87.86    P/E N/A 
Day Low $87.86    EPS $-0.15 
Volume 300,340